S-flow activates KLF2 and KLF4, transcription factors critical for suppressing atherosclerosis by modulating endothelial nitric oxide synthase (eNOS)-associated pathways, including cGMP-PKG, cAMP, and insulin signaling. This evidence concerns the gene NOS3 and atherosclerosis.